title: Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center.
authors.affiliation: Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain. karlajavier@gmail.com.
authors.forename: Karla Javier
authors.initials: KJ
authors.lastname: González
authors.affiliation: Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain.
authors.forename: Sebastian Ortiz
authors.initials: SO
authors.lastname: Zuluaga
authors.affiliation: Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain.
authors.forename: Carolina Villegas
authors.initials: CV
authors.lastname: DaRos
authors.affiliation: Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain.
authors.forename: Pedro Pérez
authors.initials: PP
authors.lastname: Rodríguez
authors.affiliation: Department of Hematology, Hospital General Universitario de Valencia, Valencia, Spain.
authors.forename: Antonio Cerveró
authors.initials: AC
authors.lastname: Martí
mesh_terms: D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000188:drug therapy*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag